Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.3K Buy
3,625
+425
+13% +$11.1K 0.01% 251
2026
Q1
$89.9K Hold
3,200
0.01% 242
2025
Q4
$79.7K Hold
3,200
0.01% 252
2025
Q3
$81.5K Hold
3,200
0.01% 246
2025
Q2
$77.6K Hold
3,200
0.01% 245
2025
Q1
$81.1K Sell
3,200
-400
-11% -$10.5K 0.01% 243
2024
Q4
$95.5K Sell
3,600
-1,500
-29% -$40.7K 0.01% 240
2024
Q3
$148K Sell
5,100
-4,550
-47% -$133K 0.02% 226
2024
Q2
$270K Sell
9,650
-9,624
-50% -$265K 0.03% 221
2024
Q1
$535K Sell
19,274
-41,658
-68% -$1.16M 0.06% 172
2023
Q4
$1.75M Sell
60,932
-15,687
-20% -$474K 0.23% 106
2023
Q3
$2.54M Sell
76,619
-16,118
-17% -$570K 0.37% 69
2023
Q2
$3.4M Sell
92,737
-4,139
-4% -$161K 0.48% 57
2023
Q1
$3.95M Sell
96,876
-650
-0.7% -$28.1K 0.59% 46
2022
Q4
$5M Sell
97,526
-11,530
-11% -$553K 0.74% 36
2022
Q3
$4.77M Hold
109,056
0.76% 29
2022
Q2
$5.72M Buy
109,056
+1,330
+1% +$67.8K 0.85% 20
2022
Q1
$5.58M Sell
107,726
-6,635
-6% -$344K 0.68% 34
2021
Q4
$6.75M Buy
114,361
+9,305
+9% +$461K 0.77% 29
2021
Q3
$4.52M Sell
105,056
-2,600
-2% -$115K 0.56% 52
2021
Q2
$4.22M Sell
107,656
-470
-0.4% -$18.3K 0.52% 58
2021
Q1
$3.92M Sell
108,126
-4,894
-4% -$174K 0.51% 62
2020
Q4
$4.16M Buy
113,020
+2,283
+2% +$83.7K 0.55% 60
2020
Q3
$3.86M Buy
110,737
+6,644
+6% +$233K 0.58% 53
2020
Q2
$3.23M Sell
104,093
-8,348
-7% -$284K 0.51% 64
2020
Q1
$3.48M Sell
112,441
-1,444
-1% -$49.2K 0.63% 48
2019
Q4
$4.23M Sell
113,885
-4,351
-4% -$155K 0.59% 48
2019
Q3
$4.03M Sell
118,236
-3,965
-3% -$144K 0.59% 51
2019
Q2
$5.02M Sell
122,201
-8,869
-7% -$352K 0.73% 33
2019
Q1
$5.28M Sell
131,070
-3,536
-3% -$142K 0.79% 30
2018
Q4
$5.57M Buy
134,606
+16,437
+14% +$682K 0.96% 19
2018
Q3
$4.94M Sell
118,169
-854
-0.7% -$32.9K 0.71% 34
2018
Q2
$4.1M Sell
119,023
-332
-0.3% -$11.3K 0.62% 46
2018
Q1
$4.02M Sell
119,355
-5,976
-5% -$205K 0.62% 46
2017
Q4
$4.31M Buy
125,331
+2,656
+2% +$90.6K 0.65% 44
2017
Q3
$4.16M Buy
122,675
+2,487
+2% +$79.9K 0.72% 33
2017
Q2
$3.83M Buy
120,188
+1,118
+0.9% +$35.3K 0.69% 39
2017
Q1
$3.86M Buy
119,070
+811
+0.7% +$25.6K 0.72% 39
2016
Q4
$3.64M Sell
118,259
-890
-0.7% -$27.2K 0.72% 39
2016
Q3
$3.83M Buy
119,149
+79
+0.1% +$2.64K 0.75% 34
2016
Q2
$3.98M Buy
119,070
+68
+0.1% +$2.17K 0.8% 30
2016
Q1
$3.35M Hold
119,002
0.71% 41
2015
Q4
$3.65M Buy
119,002
+1,254
+1% +$39.5K 0.8% 30
2015
Q3
$3.51M Sell
117,748
-1,296
-1% -$41.6K 0.8% 32
2015
Q2
$3.79M Sell
119,044
-2,166
-2% -$70.6K 0.79% 28
2015
Q1
$4M Sell
121,210
-4,796
-4% -$152K 0.82% 29
2014
Q4
$3.72M Buy
126,006
+20,068
+19% +$575K 0.78% 32
2014
Q3
$2.97M Hold
105,938
0.78% 39
2014
Q2
$2.98M Sell
105,938
-2,915
-3% -$83.1K 0.77% 37
2014
Q1
$3.32M Hold
108,853
0.88% 33
2013
Q4
$3.16M Hold
108,853
0.86% 34
2013
Q3
$2.97M Hold
108,853
0.87% 32
2013
Q2
$2.89M Buy
+108,853
New +$3.01M 0.89% 33

Other funds holding PFE

Coastline Trust's PFE Position: Q2 2026 in Review

Coastline Trust increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $11.1K and bringing the position to 3,625 shares worth $87.3K. The position accounts for 0.01% of the portfolio, ranked #251.

Coastline Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.75M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Coastline Trust held 3,625 shares of Pfizer worth $87.3K as of Q2 2026.
  • Coastline Trust bought 425 Pfizer shares in Q2 2026, an estimated $11.1K.
  • Pfizer made up 0.01% of Coastline Trust's portfolio in Q2 2026, its #251 holding.
  • Coastline Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Coastline Trust's Pfizer position peaked at $6.75M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Coastline Trust's 13F filing for Q2 2026, filed 14 Aug 2026.